Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the ...
Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, announced an interim data readout of the phase 1/2a studies of Radspherin for the treatment ...
Baxter expects to restart a second IV fluid production line shortly at its hurricane-damaged plant in western North Carolina — the country’s largest manufacturer of peritoneal dialysis and intravenous ...